.png)
Agenzia Italiana del Farmaco
home
Highlights
-
11 Apr 2025
Press releases
AIFA Board of Directors approves the reimbursability of 2 medicines
At its extraordinary meeting on 10 April 2025, the Board of Directors of the Italian Medicines Agency decided that an orphan medicine and a new chemical molecule should be eligible for reimbursement by the National Health Service (NHS).
-
11 Apr 2025
Press releases
AIFA Board approves the call for independent research on rare diseases for 2025
The call is addressed to all Italian researchers in organisations and institutions wishing to conduct non-commercial studies.
-
07 Apr 2025
Press releases
Interactive OsMed: available online the update on consumption and pharmaceutical expenditure in Italy
With just a few clicks, users can access, select and compare tables and graphs from the latest edition of the OsMed Report.
-
04 Apr 2025
Press releases
AIFA hosted the first 2025 HMA Permanent Secretariat workshop
Nisticò: “It is important to foster strategic networking”
News
14 Apr 2025
Transparency Lists
AIFA updates the Transparency Lists
07 Apr 2025
Monitoring pharmaceutical expenditure
Biosimilar medicines in Italy: AIFA reports updated
07 Apr 2025
Innovative medicinal products
Innovative medicines list: AIFA publishes March 2025 update
04 Apr 2025
Monitoring pharmaceutical expenditure
Monitoring of Pharmaceutical expenditure (January / November 2024)
03 Apr 2025
Press releases
AIFA Board approves reimbursement of 10 drugs
02 Apr 2025
Safety of medicinal products
Communication on the national management of Follow-UP questionnaires
FarmaciLine
Questions regarding drug efficacy, safety and availability
TOLL-FREE NUMBER
Services
Interactive OsMed - The use of medicines in Italy
An interactive consultation of data on the use of medicines in Italy in the general and regional population, described in terms of expenditure, volumes, typology
